{Reference Type}: Journal Article
{Title}: Analysis of the complement component C4 gene with schizophrenia subphenotypes.
{Author}: Chen CC;Howie J;Ebrahimi M;Teymouri K;Woo JJ;Tiwari AK;Zai CC;Kennedy JL;
{Journal}: Schizophr Res
{Volume}: 271
{Issue}: 0
{Year}: 2024 Sep 30
{Factor}: 4.662
{DOI}: 10.1016/j.schres.2024.07.039
{Abstract}: <B>BACKGROUND: </B>The complement component C4 gene has been identified as a strong marker for schizophrenia (SCZ) risk. The C4 gene has a complex genetic structure consisting of variable structural elements (C4A, C4B, C4L, and C4S) and compound structural forms (C4AL, C4BL, C4AS and C4BS). In addition, the variations in C4 structural forms may have a direct or indirect effect on the brain expression level of C4A and C4B proteins. Previous studies have associated C4AL with higher brain C4A expression and sex-dimorphism of C4 between males and females was observed.<BR><B>METHODS: </B>A total of 613 patients with DSM-IV SCZ or schizoaffective disorder (SCZ-AFF) were recruited to investigate the relationship between C4 gene variants and clinical characteristics of SCZ (age of onset, symptom severity, and global assessment of functioning (GAF)). This study also explored the effect of sex on the association of C4 with SCZ. 434 patients were included in the final analyses after genetic quality control.<BR><B>RESULTS: </B>We observed associations between C4 and clinical characteristics of SCZ (age of onset, symptom severity, GAF) and found significant differences when males and females were examined separately.<BR><B>CONCLUSIONS: </B>Overall, our preliminary findings encourage future investigations of C4 in SCZ-related phenotypes, including antipsychotic response and side effects. The study sample was of moderate size; therefore, further studies in larger samples are needed to extend and validate these results.